Despite major improvements in transcatheter aortic valve replacement (TAVR)
periprocedural complications in recent years, the occurrence of conduction disturbances has …

In recent times, there has been a considerable increase in the use of aortic bioprostheses
(vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to …

Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …

Transcatheter mitral valve repair, particularly edge-to-edge leaflet repair, is a well-
established alternative for patients with severe primary mitral regurgitation (MR) considered …

Background: Limited data exist regarding transcatheter mitral valve replacement (TMVR) for
patients with failed mitral valve replacement and repair. Objectives: This study sought to …

The assessment and management of tricuspid valve disease have evolved substantially
during the past several years. Whereas tricuspid stenosis is uncommon, tricuspid …

Background: Scarce data exist on the incidence of and factors associated with valve
hemodynamic deterioration (VHD) after transcatheter aortic valve replacement (TAVR) …

The presence of a small aortic annulus poses a considerable challenge in the management
of patients with severe aortic stenosis, especially in elderly women, where it is a very …

Transcatheter interventions to treat mitral and tricuspid valve disease are becoming
increasingly available because of the growing number of elderly patients with significant …

Aims We analysed the early and long-term clinical and haemodynamic outcomes of balloon-
expandable transcatheter mitral valve implantation (TMVI) in an experienced centre …